Hodgkin's Lymphoma Treatment Market Growth Accelerated By Increasing Incidence Of Hodgkin Lymphoma
![]() |
Hodgkin's Lymphoma Treatment |
Hodgkin lymphoma is a type of cancer that starts in
lymphatic system and white blood cells. Hodgkin lymphoma treatment involves
chemotherapy, radiation therapy or stem cell transplantation. Chemotherapy
drugs are used to fight cancer cells and reduce their growth and spread in the
body. Radiation therapy uses high-energy beams to kill cancer cells without
affecting surrounding healthy tissues. Stem cell transplantation is a medical
procedure wherein healthy stem cells are transfused into a patient to replace
damaged or unhealthy cells of lymphatic and immune systems.
The global Hodgkins Lymphoma Treatment Market is estimated to be valued at US$
0.59 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The increasing incidence of Hodgkin lymphoma has been a key growth driver
for the Hodgkins lymphoma treatment market. According to Cancer Research UK,
the lifetime risk of developing Hodgkin lymphoma in UK is 1 in 150 for both men
and women. WHO estimates around 72,000 new cases and 20,000 deaths due to Hodgkin
lymphoma every year globally. The growing geriatric population, which is more
susceptible to cancer, and advancements in treatment options for Hodgkin
lymphoma like personalized medicine approaches are also contributing to the
increasing demand for Hodgkin lymphoma treatment market.
Segment
Analysis
The global
Hodgkins Lymphoma Treatment market is dominated by chemotherapy sub segment.
Chemotherapy involves using powerful drugs to destroy fast-growing cancer cells
and is widely used for treating Hodgkin's lymphoma. Several types of
chemotherapy drugs can be combined to treat Hodgkin's lymphoma depending on the
stage and other factors. Since, chemotherapy is the standard first-line
treatment for Hodgkins lymphoma and is very effective against the malignant
lymphoma cells, the chemotherapy sub segment is dominating the market
currently.
Key Takeaways
The global Hodgkins
Lymphoma Treatment market analysis is expected to witness high growth
during the forecast period of 2023 to 2030.
Europe currently dominates the regional market for Hodgkins
Lymphoma Treatment due to high prevalence rates and better access to advanced
treatment options in countries like Germany, France and the UK. The Asia
Pacific region is expected to be the fastest growing market due to improving
healthcare infrastructure and increasing awareness about cancer diagnosis and
treatment in major Asian countries.
Key players operating in the Hodgkins Lymphoma Treatment market are Medtronic
PLC, ICU Medical, Inc., Viggo Medical Devices, Teleflex Incorporated, Olympus
America, Polymedicure, Ambu A/S., Verathon Inc., SourceMark, SunMed, KARL
STORZ, Flexicare (Group) Limited, and Vyaire Medical. Medtronic PLC offers
Oncology solutions for diagnosis, guidance and drug delivery. ICU Medical, Inc.
provides secure medical device connector systems for clinical application.
Get more insights on this topic: https://www.newswirestats.com/hodgkins-lymphoma-treatment-market-industry-insights-trends-hodgkins-lymphoma-treatment-market/
Explore
more information on this topic, Please visit: https://www.newsintv.com/health/genetic-symphony-precision-medicines-melody-for-tailored-health-and-wellness/
Comments
Post a Comment